首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Nonfluorescent denaturing HPLC-based primer-extension method for allele-specific expression: application to analysis of mismatch repair genes.
【24h】

Nonfluorescent denaturing HPLC-based primer-extension method for allele-specific expression: application to analysis of mismatch repair genes.

机译:非荧光变性基于HPLC的引物延伸方法,用于等位基因特异性表达:在错配修复基因分析中的应用。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Altered germline expression of genes may represent a powerful marker of genetic or epigenetic predisposition to cancer or other diseases. METHODS: We developed and validated a method of nonfluorescent primer extension that uses a single dideoxynucleotide and denaturing HPLC (DHPLC) to analyze the relative allele expression. We devised 5 independent assays for measuring allele-specific expression (ASE) to exploit different markers of mismatch repair genes MLH1 [mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)] and MSH2 [mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)]. We initially confirmed method reproducibility with genomic DNA (gDNA) from individuals heterozygous for a frequent single-nucleotide polymorphism in the MLH1 gene. After this preliminary validation with gDNA, we confirmed assay reproducibility with cDNA templates from control individuals. Relative allele expression was estimated by comparing the heights of the peaks corresponding to the 2 alleles. Results obtained with gDNA templates were used to normalize cDNA results. RESULTS: With these DHPLC-based primer-extension assays, we detected and confirmed a 5-fold imbalance in MLH1 allele expression in a mutation-negative patient with hereditary nonpolyposis colorectal cancer and in another patient with a modest degree of imbalance in MLH1 expression. Among control individuals, the relative expression of MLH1 alleles displayed a narrow range of variation. CONCLUSIONS: Independent DHPLC-based primer-extension assays for measuring and confirming ASE can be developed for different sequence variants of interest. This DHPLC application provides a cost-effective method for detecting ASE in cases for which conventional screening fails to detect pathogenic mutations in candidate genes and may be applicable for confirming ASE revealed by other methods, such as those used for transcriptome-wide analyses. .
机译:背景:基因的种系表达改变可能是癌症或其他疾病的遗传或表观遗传易感性的有力标志。方法:我们开发并验证了使用单个双脱氧核苷酸和变性HPLC(DHPLC)分析相对等位基因表达的非荧光引物延伸方法。我们设计了5个独立的测定等位基因特异性表达(ASE)的检测方法,以利用错配修复基因MLH1 [mutL同源1,结肠癌,非息肉病2型(E. coli)]和MSH2 [mutS同源2,结肠癌, 1型非息肉病(大肠杆菌)]。我们最初从MLH1基因中常见的单核苷酸多态性杂合子个体的基因组DNA(gDNA)证实了方法的可重复性。用gDNA进行初步验证后,我们确认了对照个体cDNA模板的测定可重复性。通过比较对应于两个等位基因的峰的高度来估计相对等位基因表达。用gDNA模板获得的结果用于标准化cDNA结果。结果:通过这些基于DHPLC的引物延伸试验,我们在遗传性非息肉病性结直肠癌的突变阴性患者和另一名患有MLH1表达适度失衡的患者中检测并证实MLH1等位基因表达存在5倍失衡。在对照个体中,MLH1等位基因的相对表达显示出狭窄的变异范围。结论:可以开发用于测量和确认ASE的基于DHPLC的独立引物延伸测定法,用于感兴趣的不同序列变体。在常规筛选未能检测到候选基因中的致病性突变的情况下,该DHPLC应用程序提供了一种经济有效的方法来检测ASE,并且可能适用于确认其他方法(例如用于转录组范围分析的方法)揭示的ASE。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号